AU2020289102B2 - Walking ability improver - Google Patents

Walking ability improver Download PDF

Info

Publication number
AU2020289102B2
AU2020289102B2 AU2020289102A AU2020289102A AU2020289102B2 AU 2020289102 B2 AU2020289102 B2 AU 2020289102B2 AU 2020289102 A AU2020289102 A AU 2020289102A AU 2020289102 A AU2020289102 A AU 2020289102A AU 2020289102 B2 AU2020289102 B2 AU 2020289102B2
Authority
AU
Australia
Prior art keywords
lactic acid
health
group
improving
lactic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2020289102A
Other languages
English (en)
Other versions
AU2020289102A1 (en
Inventor
Shinji Sakata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Group Holdings Ltd
Original Assignee
Asahi Group Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Group Holdings Ltd filed Critical Asahi Group Holdings Ltd
Publication of AU2020289102A1 publication Critical patent/AU2020289102A1/en
Application granted granted Critical
Publication of AU2020289102B2 publication Critical patent/AU2020289102B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
AU2020289102A 2019-06-03 2020-06-01 Walking ability improver Active AU2020289102B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019-103777 2019-06-03
JP2019103777 2019-06-03
PCT/JP2020/021637 WO2020246430A1 (ja) 2019-06-03 2020-06-01 歩行能力改善剤

Publications (2)

Publication Number Publication Date
AU2020289102A1 AU2020289102A1 (en) 2022-01-20
AU2020289102B2 true AU2020289102B2 (en) 2025-07-03

Family

ID=73652555

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2020289102A Active AU2020289102B2 (en) 2019-06-03 2020-06-01 Walking ability improver

Country Status (5)

Country Link
US (1) US20220233613A1 (https=)
EP (1) EP3978075A4 (https=)
JP (1) JP7535040B2 (https=)
AU (1) AU2020289102B2 (https=)
WO (1) WO2020246430A1 (https=)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100109661A (ko) * 2009-04-01 2010-10-11 주식회사한국야쿠르트 혈중 콜레스테롤 강하와 비만 억제 효능을 갖는 신규의 락토바실러스 커베터스 에이취와이7601 및 이를 유효성분으로 함유하는 제품
WO2012063826A1 (ja) * 2010-11-09 2012-05-18 カルピス株式会社 高タンパク質分解活性を有するラクトバチルス・ヘルベティカス菌
WO2012133533A1 (ja) * 2011-03-31 2012-10-04 大塚製薬株式会社 Ｑｏｌ改善又は持続剤
JP2013047192A (ja) * 2011-08-29 2013-03-07 Meiji Co Ltd 身体活動を促進させる乳酸菌
JP2016216408A (ja) * 2015-05-22 2016-12-22 アサヒグループホールディングス株式会社 筋肉の分解抑制剤
WO2018073963A1 (ja) * 2016-10-21 2018-04-26 森永乳業株式会社 気分プロフィール改善剤
EP3479835A1 (en) * 2016-06-30 2019-05-08 Asahi Group Holdings, Ltd. Composition for use in improvement of nutritional state
CN109789175A (zh) * 2016-08-16 2019-05-21 Md保健株式会社 预防或治疗精神障碍的含源自乳酸杆菌属细菌的囊泡的组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5422201B2 (ja) 2008-12-26 2014-02-19 株式会社ヤクルト本社 麦汁発酵物及びその利用
CN105025909B (zh) * 2013-02-27 2020-05-19 株式会社明治 应激减轻剂
JP7118344B2 (ja) 2017-05-26 2022-08-16 日環科学株式会社 筋肉改質剤
JP6469292B1 (ja) 2017-12-14 2019-02-13 アリスビジョン株式会社 観察画像を立体視させる歯科用３ｄデジタル顕微鏡システム及び歯科用ディスプレイ支持機構

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100109661A (ko) * 2009-04-01 2010-10-11 주식회사한국야쿠르트 혈중 콜레스테롤 강하와 비만 억제 효능을 갖는 신규의 락토바실러스 커베터스 에이취와이7601 및 이를 유효성분으로 함유하는 제품
WO2012063826A1 (ja) * 2010-11-09 2012-05-18 カルピス株式会社 高タンパク質分解活性を有するラクトバチルス・ヘルベティカス菌
WO2012133533A1 (ja) * 2011-03-31 2012-10-04 大塚製薬株式会社 Ｑｏｌ改善又は持続剤
JP2013047192A (ja) * 2011-08-29 2013-03-07 Meiji Co Ltd 身体活動を促進させる乳酸菌
JP2016216408A (ja) * 2015-05-22 2016-12-22 アサヒグループホールディングス株式会社 筋肉の分解抑制剤
EP3479835A1 (en) * 2016-06-30 2019-05-08 Asahi Group Holdings, Ltd. Composition for use in improvement of nutritional state
CN109789175A (zh) * 2016-08-16 2019-05-21 Md保健株式会社 预防或治疗精神障碍的含源自乳酸杆菌属细菌的囊泡的组合物
WO2018073963A1 (ja) * 2016-10-21 2018-04-26 森永乳業株式会社 気分プロフィール改善剤

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
YAMAMURA, S. ET AL.: "The effect of Lactobacillus helveticus fermented milk on sleep and health perception in elderly subjects", EUR. J. CLIN. NUTR ., vol. 63, no. 1, 2009, pages 100 - 105, XP008120343, DOI: 10.1038/sj.ejcn.1602898 *

Also Published As

Publication number Publication date
EP3978075A1 (en) 2022-04-06
WO2020246430A1 (ja) 2020-12-10
JPWO2020246430A1 (https=) 2020-12-10
EP3978075A4 (en) 2023-07-12
JP7535040B2 (ja) 2024-08-15
US20220233613A1 (en) 2022-07-28
AU2020289102A1 (en) 2022-01-20

Similar Documents

Publication Publication Date Title
JP5791009B2 (ja) 乳酸菌およびそれらを用いた飲食物又は化粧品
JP5954828B2 (ja) 皮膚状態の改善用組成物
US9439933B2 (en) Skin properties improving agent for oral administration
CN103764155B (zh) 促进身体活动的乳酸菌
JP6261688B2 (ja) Ｑｏｌ改善又は持続剤
CN111212575A (zh) 肌肉增量用组合物
JP5943342B2 (ja) 概日リズム改善剤
US20250032401A1 (en) Composition for improving skin condition
KR20220109662A (ko) 근감소증 예방 또는 개선 효과를 갖는 바실러스 벨레젠시스 및 이의 용도
WO2017047777A1 (ja) ストレス負荷解放後のセロトニン欠乏改善剤
EP1738761A1 (en) Preventive and/or remedy for inflammatory bowel diseases
US11202812B2 (en) Reducing body fat probiotic strain, composition thereof, and use thereof
AU2020289102B2 (en) Walking ability improver
JP7189393B2 (ja) 認知機能改善剤、認知機能維持剤、海馬機能改善剤及び海馬機能維持剤
JP2021045054A (ja) 抗憂うつ用組成物、幸福感向上用組成物
WO2026069916A1 (ja) 眼疲労軽減剤及び眼疲労軽減用の飲食品
HK1215854A1 (zh) 应激减轻剂

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)